Physician profile
Larry M Silver
NPI 1124008701
$5,988.54
in general payments reported to CMS, 2019-2025
30 companies · $985 in 2025
The $985 reported for 2025 was more than what 80% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $474 · 2021: $826 · 2022: $758 · 2023: $1,095 · 2024: $864 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,943.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,291.80 | 2019-2025 | Hoffmann, Allowrap, Augment Injectable |
| Smith+Nephew, INC. | $555.65 | 2019-2024 | Collagenase Santyl, Grafix Pl |
| Sandoz INC. | $364.77 | 2019-2021 | |
| Inari Medical, INC. | $189.53 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioventus LLC | $152.13 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $136.39 | 2024-2025 | Nuzyra |
| Horizon Therapeutics Plc | $124.75 | 2021-2022 | |
| Lifenet Health | $113.14 | 2023 | |
| Acera Surgical, INC. | $106.10 | 2025 | Restrata Wound Matrix |
| Organogenesis INC. | $103.68 | 2019-2021 | |
| Medtronic, INC. | $100.88 | 2023 | Venaseal |
| Alfasigma USA, INC. | $84.40 | 2021-2022 | |
| Abbvie INC. | $74.40 | 2022 | |
| Kerecis Limited | $64.60 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Axogen | $58.76 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $58.15 | 2019 | |
| Sebela Pharmaceuticals INC. | $51.20 | 2019-2022 | |
| Treace Medical Concepts, INC. | $48.38 | 2022-2024 | |
| Depuy Synthes Sales INC. | $45.67 | 2021 | |
| Nevro Corp. | $39.54 | 2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $35.00 | 2023 | |
| Orthofix Medical, INC. | $29.18 | 2023 | Physio-Stim |
| Grt US Holding, INC. | $28.97 | 2022 | |
| Advanced Oxygen Therapy INC. | $27.15 | 2019-2024 | Topical Oxygen Chamber For Extremities |
| Zimmer Biomet Holdings, INC. | $24.90 | 2019 | |
| Averitas Pharma INC. | $17.04 | 2023 | Qutenza |
| Melinta Therapeutics, LLC | $15.98 | 2019 | |
| Convatec INC. | $15.87 | 2019 | |
| Medline Industries LP | $15.47 | 2021 | |
| Medartis INC. | $15.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.